These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 974040)

  • 1. Activation of platelets by platelet activating factor (PAF) derived from IgE-sensitized basophils. IV. PAF does not activate platelet factor 3 (PF3).
    Henson PM; Landes RR
    Br J Haematol; 1976 Oct; 34(2):269-82. PubMed ID: 974040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion.
    Henson PM
    J Clin Invest; 1977 Aug; 60(2):481-90. PubMed ID: 874106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.
    Henson PM
    J Exp Med; 1976 Apr; 143(4):937-52. PubMed ID: 3618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human platelets by platelet activating factor (PAF) derived from sensitized rabbit basophils.
    O'Donnell MC; Henson PM; Fiedel BA
    Immunology; 1978 Dec; 35(6):953-8. PubMed ID: 738767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion.
    Henson PM; Oades ZG
    J Exp Med; 1976 Apr; 143(4):953-68. PubMed ID: 3619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgE-induced release of a platelet-activating factor from rabbit lung.
    Kravis TC; Henson PM
    J Immunol; 1975 Dec; 115(6):1677-81. PubMed ID: 52674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes.
    Henson PM; Pinckard RN
    Monogr Allergy; 1977; 12():13-26. PubMed ID: 335211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basophil-derived platelet-activating factor (PAF) as an in vivo mediator of acute allergic reactions: demonstration of specific desensitization of platelets to PAF during IgE-induced anaphylaxis in the rabbit.
    Henson PM; Pinckard RN
    J Immunol; 1977 Dec; 119(6):2179-84. PubMed ID: 915294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.
    Shaw JO; Henson PM
    Am J Pathol; 1980 Mar; 98(3):791-810. PubMed ID: 6987890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.
    Camussi G; Tetta C; Coda R; Benveniste J
    Lab Invest; 1981 Mar; 44(3):241-51. PubMed ID: 7464048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passage of immune complexes through vascular walls. Evidence for the role of an immediate hypersensitivity mechanism and its mediator: platelet-activating factor.
    Benveniste J
    Rheumatology; 1975; 6():293-302. PubMed ID: 53875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different requirements for intrinsic factor-Xa forming activity and platelet factor 3 activity and their relationship to platelet aggregation and secretion.
    Walsh PN; Camp E; Dende D
    Br J Haematol; 1978 Oct; 40(2):311-31. PubMed ID: 708650
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet activating factor: an inhibitor of neutrophil activation?
    O'Donnell MC; Siegel JN; Fiedel BA
    Clin Exp Immunol; 1981 Jan; 43(1):135-42. PubMed ID: 7249391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets.
    Nunez D; Kumar R; Hanahan DJ
    Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological mechanisms of human platelet involvement.
    Camussi G; Tetta C; Segoloni G; Vercellone A
    Ric Clin Lab; 1978; 8(4):262-72. PubMed ID: 734319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
    Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
    Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.